<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-GHA-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Ghana (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Ghana: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Ghana</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="GH" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="GH" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Accra</narrative>
   </name>
   <administrative code="GH" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>5.55602 -0.1969</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1189591</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1205684</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">933873</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">23515</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="GHAPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">250000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">-16320</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-MAHA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">106049</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">86083</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PSHAN2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">192200</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PSHAN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PWC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">256567</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">189000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">113420</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-YAWSON2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">4750</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-YAWSON</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-CDC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">150000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">16320</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-MAHA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">116425</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">190627</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PSHAN2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">5014</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PSHAN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PWC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">64610</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">39644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">336231</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">286814</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">73000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-ICAP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">170853</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">255641</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PWC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">51824</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">68838</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">150968</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">162750</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">22411</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GHAPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">1104</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000874">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">250000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">150000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">73000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001006">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-16320</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-13"></transaction-date>
   <value currency="USD" value-date="2021-04-13">44935</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007166">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-10"></transaction-date>
   <value currency="USD" value-date="2021-12-10">64859</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">22301</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006926">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-18845</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006927">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-7228</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006925">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">12437</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006924">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">13636</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006923">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">32630</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000753">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000242">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000978">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-19"></transaction-date>
   <value currency="USD" value-date="2020-03-19">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002034">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-19"></transaction-date>
   <value currency="USD" value-date="2020-05-19">32630</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002394">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-15"></transaction-date>
   <value currency="USD" value-date="2020-06-15">17746</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004061">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-08"></transaction-date>
   <value currency="USD" value-date="2020-10-08">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">24473</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005651">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="USD" value-date="2020-12-17">13214</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005650">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="USD" value-date="2020-12-17">3424</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-MAHA</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">86083</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">125000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">61686</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-3940</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">3940</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001515">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-17"></transaction-date>
   <value currency="USD" value-date="2021-05-17">22141</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003101">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">70769</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006426">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">65958</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000141">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-14"></transaction-date>
   <value currency="USD" value-date="2022-01-14">21518</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001169">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">187186</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PSHAN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001057">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">77479</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001223">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">15764</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001352">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-93243</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000512">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-22"></transaction-date>
   <value currency="USD" value-date="2019-11-22">186486</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">12786</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-51824</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000009">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">51824</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PWC (PricewaterhouseCoopers)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PricewaterhouseCoopers</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15644</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-20838</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">20838</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">544</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-244</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">244</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000875">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">189000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">167400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">168831</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">40068</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">110900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000876">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">113420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">120001</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">166813</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">37450</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">125300</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900002698">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">4456</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-YAWSON</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ghana-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ghana 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ghana-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ghana 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ghana-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ghana 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ghana-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ghana 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ghana-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ghana 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ghana-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ghana 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ghana-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ghana 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ghana-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ghana 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-GHA" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finalize survey methodology, tools, and TORs for data collection.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Little data exist that measure the impact of strategies designed to strengthen delivery of vaccines in the second year of life (2YL) and improve coverage of measles second dose and catch-up vaccines. The Ghana 2YL project began in 2015 to address the mult">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. All survey methodology, tools and TORs were developed for data collection. Data collection occurred during August 2020.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preliminary survey report.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Little data exist that measure the impact of strategies designed to strengthen delivery of vaccines in the second year of life (2YL) and improve coverage of measles second dose and catch-up vaccines. The Ghana 2YL project began in 2015 to address the multiple challenges that countries face when setting up a new immunization visit in the second year of life. Since then, several delivery and demand side strategies have been underway. To measure change in vaccination coverage and equity resulting from Second Year of Life (2YL) strategies implemented between 2016-2019 we propose the following data collection activities be conducted in three targeted regions: 1) Post-implementation vaccination coverage cluster survey. 2) Post-implementation health facility survey to measure changes in health worker knowledge, attitudes, and practices related to 2YL. This would include topics related to policies, communication, and data recording and reporting practices for MR, MenA, newly introduced vaccines (e.g., IPV, RTS,S), and catch-up vaccines. 3) Qualitative assessments to document key stakeholder experiences and perceived changes related to establishing and strenghtening 2YL routine immunization visits. Data from these assessments will be critical to help guide global efforts in strengthening immunization into 2YL and throughout the life course.">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. Survey data were cleaned and analysed. Preliminary reports were developed by on synthesis of data analysis. Reports were shared with Ghana Health Services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preliminary qualitative data analyzed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to strengthen 2YL platform in Ghana through a pogram assessment; workshops to transfer data analysis/writing skills to national staff; and sub-national workshops to present 2YL intervention assessment findings">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. Qualitative data were collection in August 2020. Data analysis occurred during September 2020 - January 2021. These included thematic analyses, identifying key information from informants. Information was included in preliminary reports to Ghana Health Services in April 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted dissemination meetings for other regions to share lessons learned.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to strengthen 2YL platform in Ghana through a pogram assessment; workshops to transfer data analysis/writing skills to national staff; and sub-national workshops to present 2YL intervention assessment findings">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. Dissemination meeting occurred in July 2021, with sharing of all final reports and presentations in May 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to strengthen 2YL platform in Ghana through a pogram assessment; workshops to transfer data analysis/writing skills to national staff; and sub-national workshops to present 2YL intervention assessment findings">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. Dissemination meeting occurred in July 2021, with sharing of all final reports and presentations in May 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted first analysis and technical writing workshop.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to strengthen 2YL platform in Ghana through a pogram assessment; workshops to transfer data analysis/writing skills to national staff; and sub-national workshops to present 2YL intervention assessment findings">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">1. Completed. 2. Workshops occurred at subnational level, led by in-country project managers. Each project region had a workshop where group discussions led to key workplans for future analysis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Availability of vaccinators in the selected priority districts is provided to EPI national and sub-national managers and planners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Assess existing private sector capacity that can be leveraged to improve urban immunization coverage in two districts in Accra (GA EAST) and Kumasi (ASOKWA). The choice of districts will be finalized in consultation with National EPI and the regions">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Activity delayed due to contract recently awarded in Nov and MOH&apos;s prioritization of Covid activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Country uses another system</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed 2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry digital package configured and installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry piloted in one district.
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Appointment with first lady secured and meeting concluded</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Outreach to office of 1st Lady (or 2nd Lady) for high level advocacy and support">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">A date is being negotiated for an appointment on in July with the first Lady. Update on the discussion expected in Week of July 5.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Outreach to office of 1st Lady (or 2nd Lady) for high level advocacy and support">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Information leaflets and other HPV materials developed for stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop educational documents and advocacy materials for HPV vaccines">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Awaiting for final approval from NITAG before materials for stakeholders can be developed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop educational documents and advocacy materials for HPV vaccines">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assistance with application revisions, if requested by Gavi, completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with revisions of HPV application, after review by Gavi, if necessary">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG endorsed HPV application submitted to Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in NITAG, ICC and other related meetings to discuss decision making for HPV introduction">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV application submitted to Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribute to technical content of HPV application">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and approval of HPV application with MOH/GHS and immunization stakeholders">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support development of HPV application">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meeting with CSO&apos;s and other stakeholders organized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct 1 meeting of CSOs and other stakeholders identified in the engagement plan">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct 1 meeting of CSOs and other stakeholders identified in the engagement plan">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Meeting to be held in July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Already planned meetings of the mapped stakehoders identified for possible collaboration</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leverage existing meetings of civil society organizations, Parliamentary Select committee on health, professional groupings, research institutions/academia to disseminate info packages for HPV vaccines">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Due to the current concentration by the MoH/GHS on COVID vaccination. All discussions on outstanding HPV introduction processes have been suspended in consultation with Gavi. An NCE is being developed for the outstanding funds and activities to be resumed once the COVID vaccine deployment levels are ramped up and the MoH confirm willingness to proceed with HPV</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leverage existing meetings of civil society organizations, Parliamentary Select committee on health, professional groupings, research institutions/academia to disseminate info packages for HPV vaccines">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Meeting to be held in July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised HPV application submitted to Gavi, as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with revisions of HPV application, after review by Gavi, if necessary">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Original deadline submitted have pushed back by the MOH pending NITAG&apos;s review and approval.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG and other meetings attended</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in NITAG, ICC and other related meetings to discuss decision making for HPV introduction">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in the NITAG meeting on May 14, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE data collection and report completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with HPV PIE implementation">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This is not part of PATH&apos;s TA for Ghana as the country has not introduced HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE protocol and logistics completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with HPV PIE preparations">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This is not part of PATH&apos;s TA for Ghana as the country has not introduced HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supportive supervision visits completed, as directed by EPI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="District support and supportive supervision to ensure organization, implementation, and quality of delivery for dose 2">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This is not part of PATH&apos;s TA for Ghana as the country has not introduced HPV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete second round of data cleaning</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotavac in Ghana">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Ghana has just received full IRB approval from all sentinel sites and is finalizing preparations to begin surveillance. Once surveillance is initiated, data cleaning will be routinely conducted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete first round of data cleaning</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotavac in Ghana">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Ghana has just received full IRB approval from all sentinel sites and is finalizing preparations to begin surveillance. Once surveillance is initiated, data cleaning will be routinely conducted.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotavac in Ghana">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">IRB and other site approvals are currently underway to re-initiate rotavirus surveillance at sentinel sites. Once these approvals are in place, surveillance will commence and data cleaning will routinely be conducted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised HPV application submitted to Gavi, as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with revisions of HPV application, after review by Gavi, if necessary">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Original deadline submitted have pushed back by the MOH pending NITAG&apos;s review and approval.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV application submitted to Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribute to technical content of HPV application">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Original deadline submitted have pushed back by the MOH pending NITAG&apos;s review and approval.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and approval of HPV application with MOH/GHS and immunization stakeholders">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Original deadline submitted have pushed back by the MOH pending NITAG&apos;s review and approval.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support development of HPV application">
      <location ref="GH"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Original deadline submitted have pushed back by the MOH pending NITAG&apos;s review and approval.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support four regions (two with low DTP-3 coverage and the other two with high DTP-3 coverage) to identify strategies and activities to reach missed communities and zero-dose children in their microplans">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">The WHO Country Office, in collaboration with the EPI Programme of the Ghana Health Service, has provided support to five (5) regions to develop plans that identify strategies and activities to reach poorly covered communities (under-served communities) and zero-dose children especially in hard-to-reach areas. 
Trainings were organized for these regions together with selected districts to build their capacity in the use of data to identify poorly covered areas and left out children. Due to the unrealistic population/denominator issues, qualitative information was also used to identify other poor performing areas but supposedly have high administrative coverage.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Hold a 2-day advocacy workshops in four regions (two with low DTP-3 coverage and the other two with high DTP-3 coverage) to discuss the need to reach zero-dose children, advocate for the inclusion of &apos;searching for zero-dose children&apos; and missed communities in microplans">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">The WHO Country Office has held advocacy meetings with five regional health directorates including two new regions on the need to identify under-served communities and reach zero-dose children. These discussions were held in the context of the COVID-19 pandemic which affected the operations at outreach sites and overall routine service delivery.
The WHO has provided catalytic support to regions and districts to develop microplans and implement activities outlined in these plans to reach out to under-served communities and cover all children. The Reaching Every District (RED) Approach was used as the guideline for the planning of services.
Service delivery is currently ongoing (update will be provided in the next reporting window)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Hold a 2-day advocacy workshops in four regions (two with low DTP-3 coverage and the other two with high DTP-3 coverage) to discuss the need to reach zero-dose children, advocate for the inclusion of &apos;searching for zero-dose children&apos; and missed communities in microplans">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Yet to agree on a suitable date for this activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ICC approved cMYP 2020-2024</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support development of cMYP (2020-2024)">
      <location ref="GH"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">The cMYP 2020-2024 has been completed. The meeting of the ICC to approve the document is still pending.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Upgraded temperature monitiring system installed in all immunization Walk-in Cold Rooms</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support upgrade of temparature monitoring systems for all immunization Walk-in Cold Rooms">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">There were delays in the installation of the Remote Temperature Monitoring Devices (RTMD) in 2020 due to COVID-19 travel restrictions which did not allow the consultant to travel to Ghana. Fortunately, this year, with easing of restrictions, the Ghana Country Office was able to make the necessary arrangements for the consultant to travel to Ghana in May. The RTMD installation and training was conducted from 8th May to 8th June 2021. 
A total of 17 out of 18 remote temperature monitoring devices (RTMD) have been installed in five national cold rooms/freezer rooms and 10 regional cold rooms/freezer rooms. One RTMD was not installed in the Tamale Walk-in Freezer room in the Northern region. It is currently not functioning and scheduled to be replaced. JICA plans to support the Ghana Health Service to procure a WICR for the six new regions and Northern region. Nine national and regional cold room technicians (user administrators) were trained on the phase III portal. On the job training was also done during the RTMD installation. Following the installation and use of the RTMD by the cold chain technicians at national and regional level, 27 of them were brought together at the National level for a second training on RTMD operation and trouble shooting. The consultant took opportunity to address challenges and difficulties they had experienced following installation. The final report of the activity is yet to be shared by the consultant.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support upgrade of temparature monitoring systems for all immunization Walk-in Cold Rooms">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">There were delays in the installation of the Remote Temperature Monitoring Devices (RTMD) in 2020 due to COVID-19 travel restrictions which did not allow the consultant to travel to Ghana. Fortunately, this year, with easing of restrictions, the Ghana Country Office was able to make the necessary arrangements for the consultant to travel to Ghana in May. The RTMD installation and training was conducted from 8th May to 8th June 2021. 
A total of 17 out of 18 remote temperature monitoring devices (RTMD) have been installed in five national cold rooms/freezer rooms and 10 regional cold rooms/freezer rooms. One RTMD was not installed in the Tamale Walk-in Freezer room in the Northern region. It is currently not functioning and scheduled to be replaced. JICA plans to support the Ghana Health Service to procure a WICR for the six new regions and Northern region. Nine national and regional cold room technicians (user administrators) were trained on the phase III portal. On the job training was also done during the RTMD installation. Following the installation and use of the RTMD by the cold chain technicians at national and regional level, 27 of them were brought together at the National level for a second training on RTMD operation and trouble shooting. The consultant took opportunity to address challenges and difficulties they had experienced following installation. The final report of the activity is yet to be shared by the consultant.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to overcome vaccine demand-related barriers in high risk communities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design a demand plan ( advocacy, communications, social mobilization, community engagement, and training) to generate confidence, acceptance and demand for immunization.">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This activity was completed last year following the yellow fever campaign. There are no updates from C4D for June</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Capacity building workshop (TOT) conducted for Tutors, lecturers and program officers condcuted using the guideline manual and needed amendments made to the manual for teaching in Pre-service health institutions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building for implementation of the revised social mobilization curriculum for immunization">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF jointly with national EPI and Health Promotion Division developed a concept of capacity building programme on social mobilization and vaccine confidence. The programme will be launched in August 2021 with national trainer of trainers workshop and regional roll out.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building for implementation of the revised social mobilization curriculum for immunization">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF jointly with national EPI and Health Promotion Division developed a concept of capacity building programme on social mobilization and vaccine confidence. The programme will be launched in August 2021 with national trainer of trainers workshop and regional roll out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete implementation of special strategies in the 2 urban areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement  special strategies (Urban, MOV, 2YL) to improve immunization performance in 2 urban areas ( make use of the urban assesment report  conducted by JSI in 2018)">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-allocated to provide TA for COVID-19 response</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement  special strategies (Urban, MOV, 2YL) to improve immunization performance in 2 urban areas ( make use of the urban assesment report  conducted by JSI in 2018)">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-allocated to provide TA for COVID-19 response</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to improve coverage of poorly covered areas developed and shared with all stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide TA for immunization coverage survey in consistently low performing districts using the revised EPI Cluster Survey Methodology">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-allocated to provide TA for COVID-19 response</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide TA for immunization coverage survey in consistently low performing districts using the revised EPI Cluster Survey Methodology">
      <location ref="GH"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-allocated to provide TA for COVID-19 response</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Real-time suppotive supervision and monitoring ongoing in all regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build capacity of national and regional officers in the use of e-monitoring tools (ODK)  for the implementation of the RED components (microplaning, supervision and monitoring) for real-time monitoring and action">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build capacity of national and regional officers in the use of e-monitoring tools (ODK)  for the implementation of the RED components (microplaning, supervision and monitoring) for real-time monitoring and action">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support low performing districts to implement equity-focused micro-plans for addressing identied barriers to immunization for hard to reach and urban poor populations">
      <location ref="GH"></location>
     </target>
     <actual value="Completed">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Three regions with low performing districts were supported to implement action plans to reach eligible children. The activity was integrated with vitamin A supplementation and all three regions conducted the mop up campaign in November and December 2020. These activities have been reported on in previous reports. The activity reports have been attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCEOP implemented according to the Operational Develoipment Plan and performance indicators on trac</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support CCEOP implementation to ensure that CCEOP is implemented on schedule">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Through the GAVI CCEOP support, 2,342 out of 2,343 cold chain equipment have been installed in 16 regions in the country. The post installation inspection exercise has been completed and recommendations from the report for installation company has been implemented. 
CCEOP Project is about 99.9% complete pending the installation of one (1) unit Equipment in Greater Accra Region by 11th June 2021. The Project Management Team (PMT) will conduct a follow up monitoring visit to selected installation sites by end of July 2021 to provide technical assistance to the technical staff on the ground and monitor cold chain equipment use and maintenance. 
The warranty period for maintenance of the cold chain equipment by Deng is two years, however, they could not confirm to the PMT when the warranty period starts because of the delays in implementation. This will require confirmation from UNICEF SD.
Funds have been transferred to EPI to conduct training of 32 cold chain technicians from the 16 regions in Ghana. Vestfrost will facilitate the training and have indicated their availability after July 2021. The PMT has planned to organise the training in August 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support CCEOP implementation to ensure that CCEOP is implemented on schedule">
      <location ref="GH"></location>
     </target>
     <actual value="On Track">
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">Through the GAVI CCEOP support, 2,342 out of 2,343 cold chain equipment have been installed in 16 regions in the country. The post installation inspection exercise has been completed and recommendations from the report for installation company has been implemented. 
CCEOP Project is about 99.9% complete pending the installation of one (1) unit Equipment in Greater Accra Region by 11th June 2021. The Project Management Team (PMT) will conduct a follow up monitoring visit to selected installation sites by end of July 2021 to provide technical assistance to the technical staff on the ground and monitor cold chain equipment use and maintenance. 
The warranty period for maintenance of the cold chain equipment by Deng is two years, however, they could not confirm to the PMT when the warranty period starts because of the delays in implementation. This will require confirmation from UNICEF SD.
Funds have been transferred to EPI to conduct training of 32 cold chain technicians from the 16 regions in Ghana. Vestfrost will facilitate the training and have indicated their availability after July 2021. The PMT has planned to organise the training in August 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Availability of vaccinators in priority areas (where missed communities and large numbers of zero dose children live) provided to EPI national and sub-national managers and planners for integration into national HIS.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	Support the EPI to build capacity of staff in the newly created regions/ districts in GIS technology to address inequities in immunization service">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
      <comment>
       <narrative xml:lang="EN">TEST</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strategic planning documentation (EVM-IP, CIP, cold chain rehabilitation plan) supported and submitted to MoH, incorporating VfM, sustainability and zero-dose considerations (as applicable)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	Support the EPI to conduct EVMA and incorporate recommendations from the Gavi Vaccine Wastage study">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccinators and other PHC health workers are deployed to priority areas; at least 60% of new hires (up to 80 people per region) receive training within first six months of hire</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.	Support the conduct of Immunization in Practice (IIP) at the subdistrict level staff (4 districts in 2 new regions -OTI and Bono East)">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Up to 15 regional level  EPI staff in each region trained on effective microplanning and use of data for decision making in OTI and Bono East (2 new regions).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.	Support EPI to conduct EPI MLM training for regional and district staff to promote effective microplanning and the use of data for decision making in OTI and Bono East (two new) regions">
      <location ref="GH"></location>
     </target>
     <actual>
      <location ref="GH"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
